Compass Therapeutics Inc

NASDAQ:CMPX  
2.59
+0.16 (+6.65%)
Earnings Announcements

Compass Therapeutics Reports Q4 Loss Per Share Of $0.15

Published: 03/21/2022 12:26 GMT
Compass Therapeutics Inc (CMPX) - Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.15.
Anticipated Cash Runway Into Second Half of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.